Siatis Perry C — SEC Form 4 filings
SEC reporting owner CIK 1951400. 10 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-06 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 6 filings — 98,371 shares, $20,684,884 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
- Largest priced transaction: sale of 22,381 shares @ $230.00 ($5,147,630) in AbbVie Inc., filed 2026-02-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | EVP, GC AND SECRETARY | 10 | — | 13 legs · 98,371 sh · $20,684,884 | 39 |
Form 4 filings — Siatis Perry C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 14,850 @ $232.08 · Sale (S): 5,777 @ $233.51 · Sale (S): 10,291 @ $234.66 · Sale (S): 2,600 @ $235.26 | EDGAR |
| 2026-02-27 | 4 | AbbVie Inc. (ABBV) | Option exercise (M): 7,314 @ $149.62 · Option exercise (M): 7,775 @ $175.28 · Option exercise (M): 7,292 @ $192.86 · Sale (S): 22,381 @ $230 · Option exercise (M): 7,314 (derivative) @ $149.62 · Option exercise (M): 7,775 (derivative) @ $175.28 · +1 more | EDGAR |
| 2026-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 16,290 @ $0 · Grant/award (A): 5,792 @ $0 · Grant/award (A): 5,628 @ $0 · Grant/award (A): 5,808 @ $0 · Grant/award (A): 19,500 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 7,870 @ $205.02 · Sale (S): 2,718 @ $205.38 · Sale (S): 6,811 @ $206.62 · Sale (S): 363 @ $207.19 · Option exercise (M): 2,918 @ $144.54 · Option exercise (M): 7,315 @ $149.62 · +5 more | EDGAR |
| 2025-02-24 | 4 | AbbVie Inc. (ABBV) | Sale (S): 1,784 @ $197.40 · Sale (S): 3,994 @ $198.12 | EDGAR |
| 2025-02-18 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 4,496 @ $0 · Grant/award (A): 1,844 @ $0 · Grant/award (A): 5,792 @ $0 · Grant/award (A): 5,630 @ $0 · Grant/award (A): 21,875 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 7,885 @ $178.99 · Sale (S): 6,504 @ $177.05 · Sale (S): 3,387 @ $178.04 | EDGAR |
| 2024-02-27 | 4 | AbbVie Inc. (ABBV) | Option exercise (M): 2,919 @ $144.54 · Option exercise (M): 3,519 @ $105.92 · Option exercise (M): 7,315 @ $149.62 · Sale (S): 13,753 @ $177.51 · Option exercise (M): 2,919 (derivative) @ $144.54 · Option exercise (M): 3,519 (derivative) @ $105.92 · +1 more | EDGAR |
| 2024-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 8,022 @ $0 · Grant/award (A): 2,138 @ $0 · Grant/award (A): 1,844 @ $0 · Grant/award (A): 5,792 @ $0 · Grant/award (A): 23,324 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 2,919 @ $144.54 · Disposition to issuer (D): 2,919 @ $170 · Option exercise (M): 2,919 (derivative) @ $144.54 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1951400 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →